StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
NASDAQ XXII opened at $0.19 on Wednesday. The company has a market capitalization of $1.57 million, a price-to-earnings ratio of 0.00 and a beta of 1.39. The company’s 50-day simple moving average is $0.42 and its two-hundred day simple moving average is $3.14. 22nd Century Group has a one year low of $0.15 and a one year high of $11.84.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 275.12%. The firm had revenue of $7.95 million during the quarter.
Institutional Inflows and Outflows
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Recommended Stories
- Five stocks we like better than 22nd Century Group
- 5 Top Rated Dividend Stocks to Consider
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- MarketBeat Week in Review – 9/30 – 10/4
- How to Invest in the Best Canadian Stocks
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.